Intercure Ltd
INCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.62M
Close$
Share Statistics
| Market cap | $65.62 Million |
|---|---|
| Enterprise Value | $202.16 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.63 |
| Beta | 0.35 |
| Outstanding Shares | 56,800,000 |
Return
| Return on Equity | -17.89% |
|---|---|
| Return on Assets | -10.27% |
| Return on Invested Capital | -19.40% |
Valuation & Multiples
| P/E Ratio | -5.61 |
|---|---|
| PEG | 2.56 |
| Price to Sales | 0.26 |
| Price to Book Ratio | 0.17 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | -2.19 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.06%▼ 0.23% |
|---|---|
| Total Invested | $617,905▼ 23.31% |
| Investors Holding | 14▼ 4.00% |
ESG Score
No data
About Intercure Ltd
CEO: Alexander Rabinovitch InterCure Ltd. operates as an investment holding company, with interests in the medical cannabis, biomedicine, life sciences, technology, and medical devices fields. It operates through the Investments in Biomed Portfolio Companies segme...